z

https://www.ludc.lu.se/research-0/epigenetics-and-diabetes/previous-group-members/sofia-salo - 2025-05-13

z

https://www.ludc.lu.se/research-0/epigenetics-and-diabetes/previous-group-members/annika-lundstig - 2025-05-13

x

https://www.ludc.lu.se/research-0/epigenetics-and-diabetes/previous-group-members/anders-h-olsson - 2025-05-13

x

https://www.ludc.lu.se/research-0/genomics-diabetes-and-endocrinology/clinical-co-workers - 2025-05-13

Master course in Metabolic diseases BIMM23 (7,5 credits) This course is a master course in the Biomedical programme (Lund University) which focuses on human endocrine and metabolic disorders. The course starts with an introduction to the normal physiology of the endocrine systems and how the organs involved control overall metabolism. The following week, endocrine pathophysiology is studied from d

https://www.ludc.lu.se/education-training/master-course-metabolic-diseases - 2025-05-13

. 

https://www.ludc.lu.se/research-0/cellular-autoimmunity/previous-co-workers - 2025-05-13

Diabetes Prediction in Skåne The DiPiS study is prospective study that involved screening of all newborn infants in Scania (Skåne) county in southern Sweden for risk factors of Type 1 Diabetes (T1D). The study aims at identifying infants and children in Skåne who are genetically susceptible to T1D (having high risk HLA genes) and to follow these children for 15 years to monitor if they will develo

https://www.ludc.lu.se/research/diabetes-and-celiac-disease/research-projects/dipis - 2025-05-13

Celiac disease prediction in Skåne The Celiac disease Prediction in Skåne is a spin-off investigation for celiac disease using the DiPiS cohort. It tested to what extent the tissue transglutaminase autoantibodies (tTG IgG or IgA) predict celiac disease (CD). It also tested whether environmental factors other than gluten may initiate the disease process. The genetic factor with the highest risk for

https://www.ludc.lu.se/research/diabetes-and-celiac-disease/research-projects/cipis - 2025-05-13

The Environmental Determinants of Diabetes in the Young The TEDDY study focuses on studying the role of environmental factors among children who are genetically susceptible to develop T1D. Several environmental factors are incriminated in the etiology of T1D such as gestational and childhood viral infections to such as changes in the gestational environment and infancy feeding, exposure to toxic s

https://www.ludc.lu.se/research/diabetes-and-celiac-disease/research-projects/teddy - 2025-05-13

Better Diabetes Diagnosis The BDD study is a nationwide prospective cohort study that recruits new-onset T1D who are less than 18 years old at time of diagnosis. There are 40 pediatric medical centers (95% of pediatric centers in Sweden) from most parts of Sweden participating in the BDD study. The BDD study started recruiting new incident patients of T1D from May 1st, 2005 and is still ongoing. C

https://www.ludc.lu.se/research/diabetes-and-celiac-disease/research-projects/bdd - 2025-05-13

The Global Diabetes Alliance Background The Global Diabetes Alliance (GDA) is a not-for-profit international alliance, established in 2007 and steered by a multinational collaborative panel of leading scientists in the field of diabetes. The GDA is forming a growing ‘virtual diabetes research community’, that is responding to the “tsunami” of diabetes, which threatens the well-being of millions of

https://www.ludc.lu.se/research/diabetes-and-celiac-disease/research-projects/gda - 2025-05-13

DIAbetes type 1 Prediction, Early Pathogenesis and Prevention The collaborative project DIAPREPP specifically addresses the call FP7 Cooperation Work Programme: Health-2007-2.4.3-1 Early processes in the pathogenesis of type 1 diabetes and strategies for early prevention.  The coordinator is Ezio Bonfacio, Dresden, Germany. The earliest currently identifiable process in the pathogenesis of type 1

https://www.ludc.lu.se/research/diabetes-and-celiac-disease/research-projects/diaprepp - 2025-05-13

Diabetes Prevention - Immune Tolerance DiAPREV-IT is the first prevention trial with DiamydTM, the alum formulated GAD65 “vaccine”, in children with positive islet cell autoantibodies but not yet diabetes. In the investigator initiated, placebo controlled, and double blind study, children from 4 years of age with positive GAD65-antibodies and at least one more positive islet cell autoantibody will

https://www.ludc.lu.se/research/diabetes-and-celiac-disease/research-projects/diaprev-it - 2025-05-13

Retinopathy After Diabetes Onset Diabetes retinopathy (DR) refers to any of the vascular changes in the retina. These are observed clinically as microaneurysms, dot and blot hemorrhages, edema, hard and soft exudates, neovascularization and newly formed fibrovascular tissue. The major sight-threatening manifestations of DR, macular edema and proliferative diabetes retinopathy, PDR, are the end res

https://www.ludc.lu.se/research/diabetes-and-celiac-disease/research-projects/read - 2025-05-13

Diabetes and cardiovascular risk factors DOHK is the acronym for the Swedish Diabetes och Hjärta-Kärl.   Patients diagnosed with diabetes have an increased risk to develop cardiovascular complications such as acute myocardial infarction (AMI) and stroke. Up to today, about 30 different genes have been identified as predisposing for type 1 diabetes. Furthermore, about 60 different genes have shown

https://www.ludc.lu.se/research/diabetes-and-celiac-disease/research-projects/dohk - 2025-05-13

.

https://www.ludc.lu.se/research/diabetic-complications/research-areas - 2025-05-13

LUPOP seminar May 30, 2018. What is GIS and what can it be used for? Karin Larsson Presentation (pdf) GIS centre leaflet (pdf) Air, GIS and health-research possibilities and challenges Ebba Malmqvist Anna Oudin Forskningsportalen Här finns information om forskare, projekt, publikationer, mm

https://www.lupop.lu.se/lupop-researchers/seminars-and-work-shops-0/gis-why-use-maps-research - 2025-05-13

Presentation of LUPOP on April 5, 2018 Here you will find links from the presentation of LUPOP at Medicon Village on April 5, as well as the actual presentation. LUPOP on facebook: https://www.facebook.com/LUPOPplatform  Register Utilisation Tool (RUT): https://www.registerforskning.se/stod-till-dig-som-forskar/rut/ Swedish National Data Service (SND): https://snd.gu.se/en Yammer groups for LU: ht

https://www.lupop.lu.se/lupop-researchers/documents-and-links/presentations-lupop/lupop-medicon-village - 2025-05-13

Namn (required) E-post (required) Tillhörighet / organisation Profession / titel Jag förstår att min information kommer att sparas elektroniskt vid Lunds universitet (required) Ja Leave this field blank Workshop Online workshop om verksamhetsarkitektur och forskningsdata  Vintergatan Vintergatan - ett verktyg för att skapa din verksamhetskarta Kontakt Emma-Lisa Hansson (emma-lisa [dot] hansson [at

https://www.lupop.lu.se/form/anmalan-till-nationell-arbetsgrupp-vintergatan - 2025-05-13

About LUPOP LUPOP (Lund University Population Research Platform) is an infrastructure at Lund University with the aim of facilitating sharing of population data for scientific research.Population data is information that can be directly or indirectly linked to a specific person. It may comprise age, sex, and address, but also sensitive data such as ethnicity and medical details. Handling of such d

https://www.lupop.lu.se/lupop-lund-university-population-research-platform - 2025-05-13